Isolated spleens of the mice treated with transduced HIV TCR CD8 T cells showed no signs of HIV-1-infected PBMCs; thus, peripheral CD8+ T cells modified with this potent anti-HIV TCR were capable of controlling and clearing HIV-1 infection in vivo. The gene discussed is CD8A; the disease is HIV-1 infection.